Identification of differentially expressed genes in aflatoxin B1-treated cultured primary rat hepatocytes and Fischer 344 rats

Carcinogenesis

Volumn 19, Issue 8, 1998, Pages 1451-1458

  Harris, Angela J ^a   Shaddock, Joseph G ^a   Manjanatha, Mugimane G ^a   Lisenbey, Jeffery A ^a   Casciano, Daniel A ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; ALPHA 2 MICROGLOBULIN; AMYLOID A PROTEIN; BINDING PROTEIN; CARCINOGEN; COMPLEMENT COMPONENT C4B; COMPLEMENTARY DNA; CYTOCHROME P450; GLOBULIN; GLUTATHIONE TRANSFERASE; MESSENGER RNA; MUTAGENIC AGENT; TRANSCORTIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FOOD CONTAMINATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE ISOLATION; HOMEOSTASIS; HYBRIDIZATION; LIVER CARCINOGENESIS; LIVER CELL CULTURE; MALE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SEQUENCE HOMOLOGY;

AFLATOXIN B1; ANIMALS; BLOTTING, NORTHERN; CARCINOGENS; COMPLEMENT INACTIVATOR PROTEINS; CYTOCHROME P-450 ENZYME SYSTEM; FALSE POSITIVE REACTIONS; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; GLYCOPROTEINS; MALE; MUTAGENS; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED F344; RECEPTORS, COMPLEMENT; RNA, MESSENGER; TRANSCORTIN; TRANSFERRIN;

EID: 0031661517     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.8.1451     Document Type: Article

References (70)

1. Busby, W.F. and Wogan, G.N. (1984) Aflatoxin. Chem. Carcinog., 2, 945-1136.
2. Groopman,J.D., Cain,L.G. and Kensler,T. (1988) Aflatoxin exposure in human populations; measurements and relationship to cancer. CRC Crit. Rev. Toxicol., 19, 113-143.
3. Dvorackova,I. (1976) Aflatoxin inhalation and alveolar cell carcinoma. Br. Med. J., 1, 691.
4. 1. J. Natl Cancer Inst., 40, 1195-1197.
5. Krishnamachari,K., Bhar,R., Nagarajan,V. and Tilac,T. (1975) Hepatitis due to aflatoxicosis. Lancet, 1, 1061-1063.
6. Robens,J.F. and Richard,J.L. (1992) Aflatoxins in animal and human health. Rev. Environ. Contam. Toxicol., 127, 69-94.
7. Harvey,R.B., Clark,D.E., Huff,W.E., Kubena,L.F., Corrier,D.E. and Phillips,T.D. (1988) Suppression of serum iron-binding capacity and bone marrow cellularity in pigs fed aflatoxin. Bull. Environ. Contam. Toxicol., 40, 576-583.
8. Stewart,R.G., Skeeles,J.K., Wyatt,R.D., Brown,J., Page,R.K., Russell,I.D. and Lukert,P.D. (1985) The effect of aflatoxin on complement activity in broiler chickens. Poult. Sci., 64, 616-619.
9. Thurston,J.R., Baetz,A.L. and Cheville,N.F. (1980) Acute aflatoxicosis in guinea pigs; sequential changes in serum proteins, complement, C4, liver enzymes and histopathologic changes. Am. J. Vet. Res., 41, 1272-1276.
10. Harvey,R.B., Kubena,L.F., Huff,W.E., Corrier,D.E., Rottinghaus,G.E. and Phillips,T.D. (1990) Effects of treatment of growing swine with aflatoxin and T-2 toxin. Am. J. Vet. Res., 51, 1688-1693.
11. 1-2,3-oxide: evidence for its formation in rat liver in vivo and by human liver microsomes in vitro. Biochem. Biophys. Res. Commun., 60, 1036-1043.
12. 1. Carcinogenesis, 4, 93-96.
13. 1 by liver rat microsomes and isolated hepatocytes in vitro. Chem.-Biol. Interact., 35, 145-157.
14. 1). Biochim. Biophys. Acta, 1201, 405-410.
15. 1. Proc. Natl Acad. Sci. USA, 87, 4790-4793.
16. 1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis, 12, 355-359.
17. 1 by lipoxygenases, prostaglandin H synthase and cytochrome P450 monooxygenase in guinea-pig tissues. Carcinogenesis, 13, 533-539.
18. 1 epoxidation catalysed by partially purified human liver lipoxygenase. Xenobiotica, 27, 231-241.
19. Be-DNA or ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res., 37, 4430-4438.
20. 1 in vitro. Proc. Natl Acad. Sci. USA, 74, 1870-1874.
21. 1 and its implications to quantitative cancer-risk assessment. Mutat. Res., 296, 181-198.
22. Bressac,B., Kew,M., Wands,J. and Ozturk,M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature, 350, 429-431.
23. Hsu,I.C., Metcalf,R.A., Sun,T., Welsh,J.A. and Wang,N.J. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature, 350, 427-428.
24. 1 in rat liver tumors. Proc. Natl Acad. Sci. USA, 84, 4974-4978.
25. 1-induced hepatocellular carcinoma and adenoma in the rat: Detection by denaturing gradient gel electrophoresis. Proc. Natl Acad. Sci. USA, 90, 2045-2049.
26. Solt,D. and Farber,E. (1976) New principle for the analysis of chemical carcinogenesis. Nature, 263, 701-703.
27. Davis,E., Maxuitenko,Y., Macmillan,D., Dolan,P., Roebuck,B. and Kensler,T. (1993) Oltipraz protects rats from the autopromoting effects of aflatoxin. Proc. Am. Assoc. Cancer Res., 34, 550.
28. Roebuck,B.D. and Maxuitenko,Y.Y. (1994) Biochemical mechanisms and biological implications of the toxicity of aflatoxins as related to aflatoxin carcinogenesis. In Eaton, D.L. and Groopman, J.D. (eds) The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significants. Academic Press, San Diego, CA, pp. 27-43.
29. Liang,P. and Pardee, A.B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971.
30. Hubank,M. and Schatz,D.G. (1994) Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res., 22, 5640-5648.
31. Diatchenko,L., Lau,Y.C., Campbell,A.P. et al. (1996) Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl Acad. Sci. USA, 93, 6025-6030.
32. Oldham,J.W., Casciano,D.A. and Farr,J.A. (1979) The isolation and primary culture of viable, nonproliferating rat hepatocytes. RCA Manual, 5, 1047-1050.
33. Shaddock,J.G., Heflich,R.H., McMillan,D.C., Hinson,J.A. and Casciano,D.A. (1989) Pretreatment with mixed-function oxidase inducers increases the sensitivity of the hepatocyte/DNA repair assay. Environ. Mutagen., 13, 281-288.
34. Ponte,P. and Liu,H. Unpublished communication, Berlex Biosciences, Richmond, CA.
35. Mou,L. Miller,H., Li,J., Wang,E. and Chalifour,L. (1994) Improvements to the differential display methods for gene analysis. Biochem. Biophys. Res. Commun., 199, 564-569.
36. Current Protocols in Molecular Biology (vols 1 and 2) (1994) John Wiley & Sons, UK.
37. Virca,G. D., Northemann,W., Shiels,B.R., Widera,G. and Broome,S. (1990) Simplified Northern blot hybridization using 5% sodium dodecyl sulfate. Biotechniques, 8, 370-371.
38. Hillarp,A., Wiklund,H., Thern,A. and Dahlbäck,B. (1997) Molecular cloning of rat C4b binding protein α-and β-chains. J. Immun., 158, 1315-1323.
39. Chen,L. and Hardwick,J.P. (1993) Identification of a new P450 subfamily, CYP4F1, expressed in rat hepatic tumors. Arch. Biochem. Biophys., 300, 18-23.
40. Smith,C.L. and Hammond,G.L. (1989) Rat corticosteroid binding globulin: Primary structure and messenger ribonucleic acid levels in the liver under different physiological conditions. Mol. Endrocinol., 1989, 420-426.
41. Smith,C.L. and Hammond,G.L. (1992) Hormonal regulation of corticosteroid-binding globulin biosynthesis in the male rat. Endocrinology, 130, 2245-2251.
42. Kirita,S. and Matsubara,T. (1993) cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats. Arch. Biochem. Biophys., 307, 253-258.
43. Komori,M. and Oda,Y. (1994) A major glucocorticoid-inducible P450 in rat liver is not P450 3A1. J. Biochem., 116, 114-120.
44. Liang,P. and Pardee,A.B. (1995) Recent advances in differential display. Curr. Opinion Immunol., 7, 274-280.
45. Averboukh,L., Douglas,S.A., Zhao,S., Lowe,K., Maher,J. and Pardee,A.B. (1996) Better gel resolution and longer cDNAs increase the precision of differential display. BioTechniques, 20, 918-921.
46. Shimada,T. and Guengerich,F.P. (1989) Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl Acad. Sci., USA, 86, 462-465.
47. 1 by liver rat microsomes and isolated hepatocytes in vitro. Chem. Biol. Interact., 35, 145-157.
48. 1-8,9-oxide by purified glutathione S-transferases from rats. Cancer Lett., 64, 225-233.
49. 2 mRNAs by phenobarbital. J. Biol. Chem., 261, 7952-7957.
50. Kim,S.G. and Cho,M.K. (1996) Expression of glutathione S-transferases Ya, Yb1, Yb2, Yc1 and Yc2 and microsomal epoxide hydrolase genes by thiazole, benzothiazole and benzothiadiazole. Biochem. Pharmacol., 52, 1831-1841.
51. Young,L.H., Yang,X. and Voigt,J.M. (1996) Alteration of gene expression in rat mammary tumors induced by N-methyl-N-nitrosourea. Mol. Carcinogenesis, 15, 251-260.
52. 60Co gamma rays. Electrophoresis, 17, 1638-1642.
53. Hamilton,J.W., Louis,C.A., Doherty,K.A., Hunt,S.R., Reed,M.J. and Treadwell,M.D. (1993) Preferential alteration of inducible gene expression in vivo by carcinogens that induce bulky DNA lesions. Mol. Carcinog., 8, 34-43.
54. 1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis, 16, 419-422.
55. 1-induced cell injury in cultured rat hepatocytes. Toxicology, 99, 115-123.
56. 1. Free Radical Biol. Med., 21, 139-146.
57. Fujita,T. and Nussenzweig,V. (1979) The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b. J. Exp. Med., 150, 267-276.
58. Gigli,I., Fujita,T. and Nussenzweig,V. (1979) Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl Acad. Sci. USA, 76, 6596-6600.
59. Thurston,J.R., Baetz,A.L. and Cheville,N.F. (1980) Acute aflatoxicosis in guinea pigs; sequential changes in serum proteins, complement, C4, liver enzymes and histopathologic changes. Am. J. Vet. Res., 41, 1272-1276.
60. Stewart,R.G., Skeeles,J.K. Wyatt,R.D., Brown,J., Page,R.K., Russell, I.D. and Lukert,P.D. (1985) The effect of aflatoxin on complement activity in broiler chickens. Poult. Sci., 64, 616-619.
61. Thurston,J.R., Sacks,J.M., Richard,J.L., Peden,W.M. and Driftmier,K. (1989) Complement, bacteriostaticand enzymatic activities in sera from guinea pigs given aflatoxin and/or rubratoxin. Am. J. Vet. Res., 50, 356-358.
62. Westphal,U. (1971) Steroid-Protein Interactions. Springer Verlag, New York.
63. Weiser,J.N., Do,Y.S. and Feldman,D. (1979) Synthesis and secretion of corticosteroid-binding globulin by rat liver: a source of heterogeneity of hepatic corticosteroid-binders. J. Clin. Invest., 63, 461-467.
64. Siiteri,P.K., Murai,J.T., Hammond,G.L., Nisker,J.A., Raymoure,W.J. and Kuhn,R.W. (1982) The serum transport of steroid hormones. Recent Prog. Horm. Res., 38, 457-510.
65. Singer,C.J., Khan,M.S. and Rosner,W. (1988) Characteristics of the binding of corticosteroid-binding globulin to rat cell membranes. Endocrinology, 122, 89-96.
66. Maitra,U.S., Khan,M.S., Zhang,X.H. and Rosner,W. (1990) The rat hepatic corticosteroid-binding globulin receptor: distinction from the asialoglycoprotein receptor. Endocrinology, 127, 278-284.
67. Maitra,U.S., Khan,M.S. and Rosner,W. (1993) Corticosteroid-binding globulin receptor of the rat hepatic membrane: solubilization, partial characterization and the effect of steroids on binding. Endocrinology, 133, 1817-1822.
68. Silverman,J.A. and Hill,B.A. (1995) Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter. Mol. Carcinog., 13, 50-59.
69. Sen,C.K. and Packer,L. (1996) Antioxidant and redox regulation of gene transcription. FASEB J., 10, 709-720.
70. 1 inhibition of rat hepatic nuclear RNA synthesis. J. Biol. Chem., 252, 3245-3251.